IDT Australia (ASX:IDT) Revenue: A$18.76 Mil (TTM As of Dec. 2025)


What is IDT Australia Revenue?

IDT Australia ASX:IDT Revenue is A$18.76 Mil as of Dec. 2025. The stock has 7 warning signs investors should review.

IDT Australia's revenue for the six months ended in Dec. 2025 was A$9.72 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2025 was A$18.76 Mil. IDT Australia's Revenue per Share for the six months ended in Dec. 2025 was A$0.02. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.04.

Warning Sign:

IDT Australia Ltd revenue per share has been in decline for the last 5 years.

During the past 12 months, the average Revenue per Share Growth Rate of IDT Australia was -4.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was -2.80% per year. During the past 5 years, the average Revenue per Share Growth Rate was -9.40% per year. During the past 10 years, the average Revenue per Share Growth Rate was -7.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, IDT Australia's highest 3-Year average Revenue per Share Growth Rate was 16.20% per year. The lowest was -41.40% per year. And the median was -8.35% per year.

IDT Australia  (ASX:IDT) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

IDT Australia Revenue Related Terms

IDT Australia Revenue Historical Data

* Premium members only.

The historical data trend for IDT Australia's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IDT Australia Revenue Chart

IDT Australia Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.03 12.11 6.94 13.23 19.22

IDT Australia Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.73 7.50 10.18 9.04 9.72

ASX:IDT vs ZTS, UTHR: Revenue Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, IDT Australia's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IDT Australia Revenue vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, IDT Australia's Revenue distribution charts can be found below:

* The bar in red indicates where IDT Australia's Revenue falls into.


IDT Australia Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$18.76 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of A$18.76 Mil mean?
IDT Australia (ASX:IDT) has a Revenue of A$18.76 Mil as of Dec. 2025. Revenue is the total amount a company generates as sales through its operations. View historical data on IDT Australia and its competitors.
Is IDT Australia's Revenue too high?
IDT Australia's current Revenue is A$18.76 Mil.
How does IDT Australia's Revenue compare to ZTS and UTHR?
IDT Australia's Revenue of A$18.76 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Drug Manufacturers company?
A good Revenue depends on the Drug Manufacturers industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on IDT Australia and its competitors. IDT Australia's current Revenue is A$18.76 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDT Australia stock overvalued right now?
Based on GuruFocus' analysis, IDT Australia (ASX:IDT) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.17, compared to a current price of A$0.03 — trading 81.2% below its estimated fair value. The current Revenue is A$18.76 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For IDT Australia (ASX:IDT), the current Revenue is A$18.76 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

IDT Australia Business Description

Address 45 Wadhurst Drive, Boronia, Melbourne, VIC, AUS, 3155
IDT Australia Ltd produces, develops, and supplies pharmaceutical products. It is engaged in the provision of research and development and other technical services for the pharmaceutical and allied industries. The company is involved in the manufacture of Active Pharmaceutical Ingredients (API) and Finished Dose Forms (FDF), microbiological and analytical testing, clinical packaging, and pharmacy services. The company operates in Australia, Asia, Europe, and the USA.